跳至主要内容
临床试验/NCT07668817
NCT07668817招募中不适用

Defining the Role of Hemostatic Agents in Percutaneous Nephrolithotomy: A Randomized Controlled Trial of Tract Closure Techniques

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 92 人开始时间: 2026年10月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
92
试验地点
1

研究概览

简要总结

This is a prospective, randomized controlled trial evaluating the effect of a hemostatic agent on tract-related bleeding during percutaneous nephrolithotomy (PCNL). Patients undergoing standardized PCNL will be randomized to receive either application of a hemostatic agent or no agent during tract closure, following uniform balloon occlusion, complete aspiration, and irrigation-free endoscopic assessment. The researchers hypothesize that adjunctive hemostatic agent use reduces perioperative hemoglobin decline compared with balloon tamponade alone and improves tract-related hemostasis outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least one stone ≥ 1.2cm
  • Scheduled to undergo planned PCNL
  • Age ≥ 18 years

排除标准

  • Unable to provide informed consent
  • Pre-existing nephrostomy tube
  • Multi access cases
  • Stone in calyceal diverticulum/hydrocalyx
  • Preoperatively planned overnight admission for any reason
  • Infundibular stenosis
  • Coagulation disorders
  • Other significant anatomic abnormalities

研究组 & 干预措施

Balloon Tamponade with Surgicel

Experimental

Balloon Tamponade with Surgicel as hemostatic agent.

干预措施: Surgicel (Device)

Balloon Tamponade with Floseal

Experimental

Balloon tamponade with Floseal as hemostatic agent.

干预措施: Balloon Tamponade (Procedure)

Balloon Tamponade with no hemostatic agent

Active Comparator

Balloon tamponade alone with no hemostatic agent acts as a control.

干预措施: Balloon Tamponade (Procedure)

Balloon Tamponade with Floseal

Experimental

Balloon tamponade with Floseal as hemostatic agent.

干预措施: Floseal (Device)

Balloon Tamponade with Surgicel

Experimental

Balloon Tamponade with Surgicel as hemostatic agent.

干预措施: Balloon Tamponade (Procedure)

Balloon Tamponade with Surgiflo

Experimental

Balloon tamponade with Surgilfo as hemostatic agent.

干预措施: Surgiflo (Device)

Balloon Tamponade with Surgiflo

Experimental

Balloon tamponade with Surgilfo as hemostatic agent.

干预措施: Balloon Tamponade (Procedure)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mantu Gupta

Professor of Urology

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验